June 14, 2021
2 mins read

Covaxin trials on children set to begin

Delhi AIIMS has decided to start the trial drive after the recruitment and clinical trial for single-dose Covaxin for 12-18 age group is over….reports Asian Lite News

The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children aged 6-12 years for the clinical trials of India’s first indigenously developed Covid-19 vaccine, Bharat Biotech’s Covaxin.

Sources said that the recruitment and clinical trials of the children aged 6-12 years will start from Tuesday. The trial on children aged 6-12 has already started at AIIMS Patna.

Participants would be given the vaccine after their screening report comes. The trial would ensure if the Bharat Biotech jab is suitable for children.

Delhi AIIMS has decided to start the trial drive after the recruitment and clinical trial for single-dose Covaxin for 12-18 age group is over.

After the recruitment of 6-12 year-old children, AIIMS Delhi will be conducting trials for the age group 2-6 years of children. The trials are taking place at 525 centres.

Kolkata: Health workers give the 1st dose of vaccine to the Government workers during increasing numbers of COVID 19 cases in Kolkata 24 May, 2021. (Photo: Kuntal Chakrabarty/ IANS
ALSO READ: Delhi gears up to tackle 3rd Covid wave

The screening of children for the trial of single-dose Covaxin among those aged between 2 and 18 years started at the AIIMS in New Delhi on June 7 after India’s drug regulator had granted permission for conducting the Phase 2 and 3 clinical trials of Covaxin in the age group 2 to 18 years on May 12.

AIIMS Patna, Mysore Medical College and Research Institute in Karnataka have also been selected to conduct clinical trials on children.

Covaxin is being used on adults in India’s ongoing Covid-19 vaccination drive since January 16 this year. The government last week cautioned that even though Covid-19 has not taken a serious shape among children till now, its impact can increase among them if there is a change in virus behaviour or epidemiology dynamics, and said preparations are being strengthened to deal with any such situation.

A national expert group has been formed to review Covid-19 infections in children and approach the pandemic in a renewed way to strengthen the nation’s preparedness, NITI Aayog Member (Health) V.K. Paul had said at a press conference.

“The group has examined signs which were not available four-five months before.”

ALSO READ: Delhi Metro resumes operations

Previous Story

‘Sunak’s in-laws face £5.5m demand in Amazon India tax dispute’

Next Story

Adani rules out reports on NSDL freezing accounts

Latest from -Top News

London Puts Beijing on Hold

The proposed embassy, earmarked for the site of a historic two-century-old building near the Tower of London, has been bogged down in dispute for more than three years…reports Asian Lite News The

Fiji PM Rabuka Begins First India Visit

The visit comes just weeks after India and Fiji held the 6th round of Foreign Office Consultations (FOC) in Suva, Fiji, in July 2025….reports Asian Lite News Fiji’s Prime Minister Sitiveni Ligamamada

Modi all set for Japan, China visits

By travelling to both Tokyo and Tianjin within the span of a week, Modi is set to balance strategic partnerships with Japan and cautious engagement with China – two relationships that will
Go toTop

Don't Miss

Global Covid caseload crosses 175mn

The US continues to be the worst-hit country with the

Global Covid caseload tops 354.3 mn

Amid an ongoing resurgence across the world, the global coronavirus